Thomas Halfmann is a long-time industry veteran and an advocate of digitalization in Pharmaceutical Production and Supply Chain with more than 30 years of experience in manufacturing IT and automation. After various management positions at Novartis, including Head Global Project Office, Global MES Program Manager and Global Head Biopharmaceutical Operations IT, Thomas co-founded the international life sciences consulting group HGP in 2008. HGP was acquired by NNIT in 2019. From October 2019 Thomas was the Global Head Production & Laboratory for NNIT. Since March 2023 he is focusing on research of how digitalization can improve pharmaceutical manufacturing in a fully integrated IT and automation landscape. Thomas is a frequent speaker at international life sciences conferences, author of various publications and member of various industry associations and working groups.

I'm an independent industry expert, widely recognized as an international authority in the digitalization of life sciences production. My journey has led me to become a frequent keynote speaker and presenter at prestigious international conferences, where I share insights that shape the future of our field. As a thought leader in digitalization, particularly within biopharmaceutical production, I'm dedicated to advancing the industry's knowledge base. My extensive international expert network connects me with industry-leading experts and thought leaders, fostering collaborative innovation. What sets me apart is my complete independence. I'm not employed by any company, nor do I accept assignments paid by the industry or solution providers. This independence ensures the unbiased nature of my research and insights. My commitment to staying at the forefront of industry trends is unwavering. I am a continuous researcher, always exploring the latest developments in digitalization and Industry 4.0 in biopharmaceutical production. Thank you for joining me on this journey of exploration and knowledge-sharing. Together, we're shaping the future of life sciences production.